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Sirtuin-3 (SIRT3) regulates mitochondrial quality and is involved in the anti-
ageing and pro-longevity actions of caloric restriction (CR). Here, we show
that CR upregulates the mature form of SIRT3 and mitochondrial intermedi-
ate peptidase (MIPEP), a mitochondrial signal peptidase (MtSPase), in white
adipose tissue. We also demonstrate that upregulation of mature SIRT3 is
dependent on MIPEP in 3T3-L1 cells, suggesting that MIPEP may con-
tribute to the maintenance of mitochondrial quality during CR via activation
of SIRT3. This novel mechanism of SIRT3 activation through MIPEP facili-
tates the elucidation of additional molecular pathways of CR.
Keywords: caloric restriction; mitochondrial intermediate peptidase;
sirtuin-3
Caloric restriction (CR) extends lifespan and suppresses
age-associated pathophysiology in various animal mod-
els, but the molecular mechanisms underpinning these
features remain debatable. We recently reported that
CR activates mitochondrial biogenesis via sterol regula-
tory element-binding protein 1c (Srebp-1c) in white adi-
pose tissue (WAT), but not other tissues, suggesting
specific activation in WAT may play a pivotal role in
the beneficial effects of CR [1].
Sirtuins (SIRTs), classified to include seven mam-
malian homologs of the yeast SIR2 gene, mediate the
effects of CR on life span extension in yeast and
Caenorhabditis elegans. SIRTs play an important role
in adaptive responses to various stresses, including CR
and metabolic stress [2]. SIRT3, a member of the
SIRT family that localizes within the mitochondrial
matrix, regulates mitochondrial dynamics and protein
quality control by modulating acetylation levels of
metabolic enzymes [3]. Indeed, SIRT3-dependent mito-
chondrial adaptations may be a central mechanism of
the beneficial actions of CR [4]. Thus, to assess the
relationship between CR and mitochondrial function,
we investigated detailed changes of SIRT3 expression
in mice WAT under CR conditions.
Abbreviations
AL, ad libitum; COX4, cytochrome c oxidase subunit 4; CR, caloric restriction; MDH2, malate dehydrogenase 2; MIPEP, mitochondrial inter-
mediate peptidase; MnSOD, manganese superoxide dismutase; MPP, mitochondrial processing peptidase; MtSPase, mitochondrial signal
peptidase; SIRT, sirtuin; Srebp-1c, sterol regulatory element-binding protein 1c; WAT, white adipose tissue.
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Materials and methods
Animals and diet
Animal experiments were approved by the Ethics Review
Committee for Animal Experimentation at Tokyo Univer-
sity of Science or the Tsukuba University Animal Care and
Use Committee.
Male mice (B6/129S6 background) were maintained
under specific-pathogen free (SPF) conditions at 23 °C with
12-h light/dark cycles in the Laboratory Animal Center at
the Faculty of Pharmaceutical Sciences, Tokyo University
of Science, and provided with water and food ad libitum
(AL) with a CR-LPF diet (Oriental Yeast, Tokyo, Japan).
From 3 months of age, mice were divided into two groups:
one fed AL and the other CR (70% of AL energy intake).
At 8 months of age, all mice were killed under anaesthesia
with isoflurane inhalation (Mylan, Canonsburg, PA, USA).
CR and AL groups were further divided into two treat-
ments (fast or fed) as follows: half of CR mice were fasted
overnight for approximately 20 h prior to killing, while the
other half were killed without removing food; similar to
CR mice, half of AL mice were killed 20 h after the
removal of food (which occurred when lights were turned
off), while the other half were killed without removing
food. After mice were killed, epididymal WAT was col-
lected. A subsample of isolated WAT was immediately
diced, frozen in liquid nitrogen, and stored at 80 °C. In
addition, male Sirt3 wild-type (+/+) and deficient (/)
mice were purchased from Jackson Laboratory (Bar Har-
bor, ME, USA) and maintained under SPF conditions in
the Laboratory Animal Resource Center, University of
Tsukuba. At 15 weeks of age, all mice were euthanized by
decapitation for harvesting of epididymal WAT as
described above.
Cells and reagents
3T3-L1 cells purchased from RIKEN Bioresource Center
(Ibaraki, Japan) were maintained in low-glucose Dulbecco’s
modified Eagle medium (Wako, Osaka, Japan) supple-
mented with 10% fetal bovine serum (Bovogen Biologicals,
Essendon, Vic., Australia) and 1% penicillin/streptomycin
(Sigma-Aldrich, St. Louis, MO, USA). MG132 was pur-
chased from Wako.
RNA purification and reverse transcription–
polymerase chain reaction (RT-PCR)
RNA purification and RT-PCR were performed as previ-
ously reported by our laboratory [5]. In brief, total RNA
was extracted from cells using RNAiso PLUS (Takara,
Shiga, Japan) and purified with a FastPure RNA kit
(Takara) according to the manufacturer’s protocol. Purified
RNA was subjected to reverse transcription with
PrimeScript Reverse Transcriptase (Takara) and random
hexamers (Takara). Quantitative RT-PCR was performed
using an Applied Biosystems 7300 real-time PCR system
(Foster City, CA, USA) and SYBR Premix Ex Taq II
(Takara) according to the manufacturer’s protocol.
Sequences of primers used for RT-PCR were as follows:
Mipep (Forward: 50-CAA AGG AGA GGT GTG GTG
TAA TG-30, Reverse: 50-GGA AGA TTC AGC ATG
AGA ACG AC-30), Cox4 (Forward: 50-CAT TTC TAC
TTC GGT GTG CCT TC-30, Reverse: 50-CAC ATC AGG
CAA GGG GTA GTC-30), Mdh2 (Forward: 50-AGG TTG
ACT TTC CCC AAG ACC-30, Reverse: 50-CAT AAG
CCA TGG ACA GAG TGG-30), Sirt3 (Forward: 50-CGT
TGT GAA ACC CGA CAT TG-30, Reverse: 50-TCC CCT
AGC TGG ACC ACA TC-30), Pmpca (Forward: 50-AGT
TTG GAC AAT TCT GTA CCG TAG G-30, Reverse: 50-
TCG TCT TTG CTG TCA AAT CGA G-30), Pmpcb (For-
ward: 50-AAA ACT CTG GGC TCT CAA CGT G-30,
Reverse: 50-ACA GTC TGC TCT CTG GAG GTA TAG
G-30) and Tbp (Forward: 50-CAG TAC AGC AAT CAA
CAT CTC AGC-30, Reverse: 50-CAA GTT TAC AGC
CAA GAT TCA CG-30).
Protein extraction and immunoblotting
Tissues and cells were lysed with lysis buffer (50 mM Tris/
HCl, pH 6.8, 2% sodium dodecyl sulphate and 5% glyc-
erol) and boiled for 5 min and sonicated. Protein concen-
trations within soluble fractions were determined using a
Pierce BCA Protein Assay Kit (Thermo Scientific, Wal-
tham, MA, USA). Extracted protein samples were stan-
dardized by the addition of lysis buffer, 2-mercaptoethanol
and bromophenol blue to obtain final concentrations of
5% and 0.025%, respectively, before boiling samples for
5 min. Fifteen micrograms of each protein sample was sub-
jected to SDS/PAGE with 12% (high-density) or 8% acry-
lamide gels before transfer to nitrocellulose membranes.
Membranes were blocked with 2.5% skim milk and 0.25%
bovine serum albumin in Tris-buffered saline (50 mM Tris,
pH 7.4 and 150 mM NaCl) containing 0.1% Tween 20
(TTBS) for 60 min at room temperature, and then probed
with appropriate primary antibodies overnight at 4 °C. Pri-
mary antibodies against SIRT3 (Cell Signaling Technology
(CST), Beverly, MA, USA), MIPEP (Santa Cruz Biotech-
nology, San Francisco, CA, USA), COX4 (CST), MDH2
(CST), manganese superoxide dismutase (MnSOD) (CST),
MnSOD (acetyl K122) (Abcam, Cambridge, UK), FLAG
(Sigma), b-ACTIN (Sigma), a-TUBULIN (Sigma) and
GAPDH (Santa Cruz) were used. After several washes with
TTBS, membranes were incubated with an appropriate sec-
ondary antibody (horseradish peroxidase-conjugated F(ab0)
2 fragment of goat anti-mouse IgG or anti-rabbit IgG;
Jackson ImmunoResearch, West Grove, PA, USA) for
60 min at room temperature. After washing with TTBS,
membranes were incubated with ImmunoStar LD reagent
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(Wako). Specific proteins were visualized with LAS3000
(Fujifilm, Tokyo, Japan), and data were analysed using
MULTIGAUGE software (Fujifilm).
Vector construction
A retroviral vector expressing FLAG-Sirt3 was constructed
by excising cDNA encoding FLAG-mouse Sirt3 from
mSIRT3-L (Addgene plasmid 33309) and cloning this frag-
ment into EcoRI- and ApaI-digested pMXs-AMNN-puro,
the details of which were published in our previous study [1].
The pMXs-puro-mU6 vector was constructed as previ-
ously reported [5]. A mouse shRNA against the Mipep
(shMipep) expression vector was designed using siDirect 2.0
(http://siDirect2.RNAi.jp/). Sequences of oligonucleotides
for shMipep and shGFP (used as a negative control) were
as follows: shMipep (50-GTG ATG AGA AGT TTA TGG
GGT TTC AAG AGA ACT CCA TAA GCT TCT TAT
CAC TTT TT-30) and shGFP (50-GGC TAT GTC CAG
GGG CGC ATC TTC AAG AGA GGT GCG CTC CTG
GAC GTA GCC TTT TT-30).
FLAG-Sirt3 expression and Mipep knockdown in
3T3-L1 cells
Stable FLAG-Sirt3 – expressing and Mipep-knockdown cell
lines were generated using retroviral infection, as previously
reported [5]. The produced vectors (pMXs-AMNN-puro-
Sirt3, pMXs-puro-mU6-shMipep or shGFP) were trans-
fected into Plat-E cells with FuGENE 6 (Promega,
Madison, WI, USA), according to the manufacturer’s pro-
tocol. Virus-containing culture supernatants were collected
2 days after transfection and filtered through 0.22-lm filters
(Millipore, Billerica, MA, USA). To obtain stable FLAG-
Sirt3 – expressing, Mipep- or GFP-knockdown cell lines
3T3-L1 cells were incubated with virus-containing medium
for 2 days, followed by selection with 2 lgmL1 of puro-
mycin (Sigma) for 5 days.
Statistical analysis
Data are presented as mean  standard error of the mean
(SEM). Statistical analyses were performed using Student’s
t-test or Tukey’s test. P-values < 0.05 were considered sta-
tistically significant.
Results and Discussion
CR upregulates the mature form of SIRT3 protein
in WAT
Initially, we examined SIRT3 protein expression levels
in the WAT of CR mice. Immunoblotting with an
anti-SIRT3 antibody yielded two bands (approxi-
mately 37 and 28 kDa, as estimated by molecular
weight markers). Interestingly, the lower band was
upregulated in CR groups, while, in contrast, the
upper band was reduced in these animals (Fig. 1A).
To verify the identity of these bands to be SIRT3 pro-
teins, we performed immunoblotting of WAT from
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Fig. 1. CR upregulated the mature form of SIRT3 in mice WAT. (A) Protein levels of SIRT3 from the fed and fasted group of both ad libitum
(AL) and CR mice were obtained by immunoblotting. The left panel is the representative image. The right graphs are quantitative data. (B)
SIRT3 protein levels of Sirt3 wild-type (+/+) and deficient (/) mice were obtained by immunoblotting with high-density gels. (C) mRNA
levels of Sirt3 in AL and CR mice WAT were obtained by real-time RT-PCR. Coomassie brilliant blue (CBB) staining was used as a loading
control in immunoblotting. Tbp was used as an internal control in real-time RT-PCR. Values shown in all panels are means  SEM (n = 3–4
per group). *P < 0.05, ***P < 0.001, analysed by Student’s t-test or Tukey’s test.
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Sirt3-deficient mice using high-density gels. Conse-
quently, no bands were detected around these molecu-
lar weights in the WAT of Sirt3-deficient mice
(Fig. 1B), confirming that both bands were SIRT3
proteins. Notably, we did not observe an elevation of
Sirt3 mRNA in the WAT of CR mice (Fig. 1C),
although CR has been reported to upregulate Sirt3
mRNA expression in WAT [3]. The 28-kDa protein
has previously been reported to be the processed pro-
duct, or activated mature form, of SIRT3 [6]. There-
fore, we hypothesized that CR may induce the
processing of SIRT3 protein, leading to its activation.
CR upregulates MIPEP in WAT
More than 99% of mitochondrial proteins are synthe-
sized as precursor forms, the majority of which possess
an N-terminal signal sequence for mitochondrial tar-
geting. Signal sequences of mitochondrial proteins are
proteolytically cleaved and activated by specific mito-
chondrial signal peptidases (MtSPases) present within
mitochondria [7]. A previous report showed that
SIRT3 is cleaved by mitochondrial processing pepti-
dase (MPP), a MtSPase [6]. Therefore, we examined
mRNA levels of Pmpca, which encodes MPPa (recog-
nition unit), and Pmpcb, which encodes MPPb (en-
zyme unit), in the WAT of CR mice. However, CR
did not alter mRNA levels of either Pmpca or Pmpcb
(Fig. 2A,B). To identify the MtSpase upregulated by
CR, we reanalysed DNA microarray data from the
WAT of CR rats (Gene Expression Omnibus, acces-
sion code: GSE30668) [8]. Consequently, we found
that CR upregulated mitochondrial intermediate pepti-
dase (MIPEP), a finding that was verified by real-time
RT-PCR in the WAT of mice (Fig. 2C). Both cyto-
chrome c oxidase subunit 4 (COX4) and malate dehy-
drogenase 2 (MDH2) are reportedly processed by
MIPEP [9]. Indeed, CR upregulated the expression
level of MIPEP, COX4 and MDH2 (Fig. 2D), indicat-
ing that CR may activate the processing of SIRT3 pro-
teins through upregulation of MIPEP.
MIPEP contributes to SIRT3 activation in
adipocytes
MIPEP is known to cleave proteins processed by
MPP, namely, contributing to the second of two suc-
cessive cleavage steps [10]. If SIRT3 protein is cleaved
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Fig. 2. CR upregulated MIPEP, one of MtSPases in mice WAT. (A–C) mRNA levels of the MtSPases, Pmpcb (A), Pmpca (B) and Mipep (C)
in AL and CR mice were obtained by real-time RT-PCR. (D) Protein levels of MIPEP, COX4 and MDH2 in WAT from AL and CR mice were
obtained by immunoblotting. Tbp was used as an internal control in real-time RT-PCR. Coomassie brilliant blue (CBB) staining was used as a
loading control in immunoblotting. Values shown in all panels are means  SEM (n = 3–4 per group). *P < 0.05, **P < 0.01, ***P < 0.001,
analysed by Student’s t-test.
Fig. 3. Maturation of SIRT3 was dependent on MIPEP. (A) Protein levels of SIRT3 in mock or FLAG-Sirt3 expressing 3T3-L1 cells were
obtained by immunoblotting with high-density gel (15%). Cells were treated with or without 10 lM MG132 for 6, 12, 24 and 48 h. b-ACTIN
was used as a loading control. (B) Protein levels of MIPEP, SIRT3, COX4 and MDH2 in shMipep 3T3-L1 cells were obtained by
immunoblotting. GAPDH was used as a loading control. The lower panel is the quantitative data. (C) mRNA levels of Sirt3, Cox4 and Mdh2
in shMipep 3T3-L1 cells were obtained by real-time RT-PCR. Rps18 was used as an internal control. (D) Expression levels of Ac-MnSOD
(K122 acetylated MnSOD) and total MnSOD proteins in shMipep 3T3-L1 cells were obtained by immunoblotting. a-TUBULIN was used as a
loading control. Values shown in all panels are means  SEM (n = 4–6). *P < 0.05, **P < 0.01, analysed by Student’s t-test.
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in such processing steps, immunoblotting for SIRT3
should display at least three different molecular weight
forms: precursor, intermediate and mature. However,
only two forms, presumed to be the precursor
(37 kDa) and mature (28 kDa) forms, were found in
mice WAT (Fig. 1A,B). One probable reason for this
is that mitochondrial proteins (after initial processing
by MPP) may be subject to degradation [9,11]. There-
fore, to facilitate the detection of SIRT3 intermediates,
and further precursor forms, we treated 3T3-L1 prea-
dipocytes expressing exogenous FLAG-Sirt3 with the
proteasome inhibitor MG132. This treatment permit-
ted the observation of three bands, predicted to be
precursor, intermediate, and mature forms of SIRT3
present in these cells (Fig. 3A). Moreover, the same
band pattern was detected using an anti-FLAG anti-
body (Fig. 3A). Collectively, these results support the
processing of SIRT3 protein by two successive steps.
To evaluate whether MIPEP contributes to SIRT3
activation, we performed knockdown of Mipep in 3T3-
L1 cells and verified a decrease of mature SIRT3
in vitro. We then examined expression of the mature
form of SIRT3 in 3T3-L1 cells expressing shRNA
against Mipep. Mipep knockdown diminished COX4
and MDH2 proteins in addition to the mature form of
SIRT3 (Fig. 3B), whereas mRNA expression was unal-
tered (Fig. 3C). Moreover, Mipep knockdown
increased the acetylation level of K122 on MnSOD, a
substrate of SIRT3 [12], reflecting downregulation of
SIRT3 deacetylase activity (Fig. 3D). These results
suggested that MIPEP positively regulated expression
of the mature form of SIRT3, most likely by mediat-
ing the processing of an intermediate form.
Conclusions
Herein, we demonstrated that CR increased the mature
form of SIRT3 in WAT, likely in a MIPEP-dependent
manner, thus presenting the possibility that SIRT3 pro-
teins are processed in two successive steps. Taken
together, the induction of MIPEP during CR may
enhance the processing of intermediate SIRT3 into its
mature form. Given these findings, we propose a novel
activation mechanism of SIRT3 by MIPEP, supporting
an important role for MIPEP in the maintenance of
mitochondrial quality during CR via SIRT3 activation.
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